Company Overview of Aptalis Pharma Inc.
Aptalis Pharma Inc., a specialty pharmaceutical company, develops therapies cystic fibrosis and gastrointestinal disorders primarily in the United States, the European Union, and Canada. The company manufactures and commercializes various pharmaceutical products, including ZENPEP, ULTRASE, and VIOKASE products for the treatment of exocrine pancreatic insufficiency (EPI); PANZYTRAT for use in the treatment of EPI and pancreatic enzyme deficiency; CANASA for the treatment of ulcerative proctitis; and SALOFALK for the treatment of inflammatory bowel diseases, such as ulcerative colitis, ulcerative proctitis, and Crohn’s disease. It also offers CARAFATE and SULCRATE product lines for the treatme...
22 Inverness Center Parkway
Birmingham, AL 35242
Founded in 2007
Key Executives for Aptalis Pharma Inc.
President of Pharmaceutical Technologies
Compensation as of Fiscal Year 2015.
Aptalis Pharma Inc. Key Developments
Aptalis Pharmaceutical Technologies Presents at BIO-Europe Spring 2015, Mar-10-2015 03:00 PM
Jan 29 15
Aptalis Pharmaceutical Technologies Presents at BIO-Europe Spring 2015, Mar-10-2015 03:00 PM. Venue: Paris Expo - Porte de Versailles, Hall 5, Paris, France.
Aptalis Pharmaceutical Technologies Presents at 8th Annual BIO Europe Spring 2014, Mar-11-2014 02:30 PM
Jan 21 14
Aptalis Pharmaceutical Technologies Presents at 8th Annual BIO Europe Spring 2014, Mar-11-2014 02:30 PM. Venue: OVAL Lingotto, Turin, Italy.
Aptalis Pharma Inc., Forest Laboratories Inc. - M&A Call
Jan 8 14
To discuss the agreement to acquire Aptalis
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries